Company Profile
MANGOCEUTICALS Stock Price, News & Analysis
- Ticker:
- MGRX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.53 USD (+23.85%)
Close
Last updated: August 6, 2026
6.58M USD
Market cap
Why the stock is moving
Following the latest company update, “Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure”, MGRX closed up 23.9% at $0.5270 on Aug 6, 2026. The move occurred in the trading session associated with this company update.
Company overview
Business overview
Mangoceuticals is a consumer-facing healthcare company focused on men’s health, telehealth, and branded wellness products. Its story is centered on direct-to-consumer distribution rather than classic biotech innovation.
Geographic Base and Sector Classification
Mangoceuticals is headquartered in the United States and listed on NASDAQ. It sits in consumer health and telehealth rather than biotechnology.
Business Model Characteristics
The business model depends on brand building, digital acquisition, and consumer demand for health and wellness products. Investors watch user growth, gross margin, and whether the company can build a sustainable consumer franchise.
Position Within the Biotechnology Landscape
Mangoceuticals is outside biotech and belongs in the consumer health / digital health bucket. Its stock is driven more by brand execution and customer acquisition than by drug catalysts.
Future catalysts
Mangoceuticals’ catalysts are its men’s-health products, consumer marketing, and any update that shows the brand can keep growing. The story is mainly a consumer-demand one.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MANGOCEUTICALS (MGRX)?
MANGOCEUTICALS (MGRX) most recently closed at 0.53 USD, a +23.85% move versus the previous session.
What is the market cap of MANGOCEUTICALS (MGRX)?
MANGOCEUTICALS currently has a market capitalization of 6.58M USD on BioPharmSignal.
What does MANGOCEUTICALS do?
Mangoceuticals is a consumer-facing healthcare company focused on men’s health, telehealth, and branded wellness products. Its story is centered on direct-to-consumer distribution rather than classic biotech innovation.
On which exchange is MGRX stock listed?
MANGOCEUTICALS (MGRX) is associated with NASDAQ, United States, Biopharma.
What is Mangoceuticals?
Mangoceuticals’ catalysts are its men’s-health products, consumer marketing, and any update that shows the brand can keep growing.
Which conditions is MANGOCEUTICALS targeting with Mangoceuticals?
Mangoceuticals’ catalysts are its men’s-health products, consumer marketing, and any update that shows the brand can keep growing.
How does MANGOCEUTICALS describe recent progress with Mangoceuticals?
Mangoceuticals’ catalysts are its men’s-health products, consumer marketing, and any update that shows the brand can keep growing.
What future catalysts are investors watching for MANGOCEUTICALS?
Mangoceuticals’ catalysts are its men’s-health products, consumer marketing, and any update that shows the brand can keep growing. The story is mainly a consumer-demand one.